Home » AireRx Warning Letter Cites Complaint Handling, Marketing
AireRx Warning Letter Cites Complaint Handling, Marketing
A Tennessee maker of wheelchair components received an FDA warning letter after the agency found problems with the company’s documentation and complaint-handling procedures. According to the July 27 letter, AireRx Healthcare did not evaluate complaints to determine if they represented MDR-reportable events.
The GMP Letter
The GMP Letter
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May